During the past decade, Lexmedica conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 33 clinical trials were completed, i.e. on average, 89.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 24 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lexmedica" #1 sponsor was "Shire" with 11 trials, followed by "Celgene" with 9 trials sponsored, "Pfizer" with 9 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Takeda" with 7 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lexmedica" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Lexmedica" are "Ulcerative Colitis" (26 trials), "Crohn's Disease" (9 trials), "Crohn Disease" (7 trials), "Colitis, Ulcerative" (5 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Lexmedica" in a lesser frequency.

Most popular intervention types in "Lexmedica" are "Drug" (50 trials), "Other" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Etrolizumab" (5 trials), "Ontamalimab" (4 trials), "Ozanimod" (4 trials) and "GED-0301" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lexmedica" are 49 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Lexmedica". undefined are not yet recruiting, 6 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Lexmedica, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Lexmedica, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".